We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $133B
1-Year Est. Return 43.5%
This Fund
S&P 500
This Quarter Est. Return
+14.19%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$117B
AUM Growth
+$9.87B
Cap. Flow
-$1.11B
Cap. Flow %
-0.95%
Top 10 Hldgs %
30.52%
Holding
4,391
New
216
Increased
2,182
Reduced
1,537
Closed
202

Top Buys

Rank Stock Value
1
COF icon
Capital One
COF
+$89.2M
2
FLUT icon
Flutter Entertainment
FLUT
+$43.9M
3
OKTA icon
Okta
OKTA
+$32.1M
4
CHWY icon
Chewy
CHWY
+$31.8M
5
COIN icon
Coinbase
COIN
+$26.9M

Sector Composition

Rank Sector Weight
1 Technology 31.83%
2 Financials 13.86%
3 Consumer Discretionary 10.91%
4 Healthcare 9.41%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSFE icon
2426
Paysafe
PSFE
$352M
$639K ﹤0.01%
50,648
+33
+0.1% +$451
EON
2427
DELISTED
E.ON AG ADS (REPTG 1/3 ORD SHS)
EON
$639K ﹤0.01%
34,473
-464
-1% -$8.6K
ARHS icon
2428
Arhaus
ARHS
$1.37B
$638K ﹤0.01%
73,615
-146
-0.2% -$1.22K
TTGT icon
2429
TechTarget
TTGT
$265M
$637K ﹤0.01%
81,924
+6,077
+8% +$48.3K
NMR icon
2430
Nomura Holdings
NMR
$29B
$636K ﹤0.01%
96,609
-882
-0.9% -$5.16K
MTW icon
2431
Manitowoc
MTW
$727M
$635K ﹤0.01%
52,801
-835
-2% -$8.19K
GLRE icon
2432
Greenlight Captial
GLRE
$505M
$633K ﹤0.01%
44,026
-967
-2% -$13.3K
TBPH icon
2433
Theravance Biopharma
TBPH
$878M
$632K ﹤0.01%
57,308
-4,946
-8% -$48.1K
NRIM icon
2434
Northrim BanCorp
NRIM
$599M
$632K ﹤0.01%
27,100
+1,900
+8% +$39.5K
CNDT icon
2435
Conduent
CNDT
$241M
$630K ﹤0.01%
238,543
-1,818
-0.8% -$4.27K
ATYR
2436
aTyr Pharma
ATYR
$54.2M
$629K ﹤0.01%
+124,158
New +$488K
CLBK icon
2437
Columbia Financial
CLBK
$1.21B
$628K ﹤0.01%
43,273
+413
+1% +$5.88K
FRPH icon
2438
FRP Holdings
FRPH
$425M
$628K ﹤0.01%
23,338
+4,117
+21% +$112K
NUTX
2439
Nutex Health
NUTX
$1.18B
$626K ﹤0.01%
5,032
+4,935
+5,088% +$637K
DHIL
2440
DELISTED
Diamond Hill
DHIL
$625K ﹤0.01%
4,302
+148
+4% +$20.4K
NEXN
2441
Nexxen International
NEXN
$598M
$624K ﹤0.01%
59,926
+55,469
+1,245% +$564K
TREE icon
2442
LendingTree
TREE
$444M
$621K ﹤0.01%
16,754
+1,875
+13% +$75.7K
PUB
2443
DELISTED
PUBLICIS SA ADS (1 ADS = 1C0M)
PUB
$621K ﹤0.01%
22,753
-945
-4% -$25.8K
SHYF
2444
DELISTED
The Shyft Group
SHYF
$621K ﹤0.01%
49,499
-2,001
-4% -$19.6K
CVLG icon
2445
Covenant Logistics
CVLG
$865M
$620K ﹤0.01%
25,716
-461
-2% -$9.99K
MAGN
2446
Magnera Corp
MAGN
$443M
$619K ﹤0.01%
51,269
+49,757
+3,291% +$685K
PHAT icon
2447
Phathom Pharmaceuticals
PHAT
$742M
$619K ﹤0.01%
64,557
+7,818
+14% +$43.3K
CBNK icon
2448
Capital Bancorp
CBNK
$617M
$617K ﹤0.01%
18,378
+3,545
+24% +$109K
SPY icon
2449
State Street SPDR S&P 500 ETF Trust
SPY
$815B
$617K ﹤0.01%
998
SPOK icon
2450
Spok Holdings
SPOK
$230M
$615K ﹤0.01%
34,805
+1,773
+5% +$28.6K

Similar funds

RhumbLine Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, RhumbLine Advisers held 4,391 positions worth $117B, up 9.2% from $107B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

RhumbLine Advisers's Q2 2025 filing shows 216 new, 2,182 increased, 1,537 reduced and 202 closed positions. Its largest new stake was Ralliant Corp: 320,982 shares worth $15.6M. The largest sale was Discover Financial Services, an estimated $91M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q2 2025 buy was Ralliant Corp: 320,982 shares worth $15.6M.
  • RhumbLine Advisers added most to Capital One in Q2 2025, an estimated $89.2M increase.
  • RhumbLine Advisers's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $75.5M.
  • RhumbLine Advisers fully exited Discover Financial Services in Q2 2025, selling an estimated $91M.
  • RhumbLine Advisers's ten largest holdings make up 31% of its $117B portfolio in Q2 2025.
  • RhumbLine Advisers opened 216 new positions and closed 202 in Q2 2025.
  • RhumbLine Advisers's portfolio value rose 9.2% quarter-over-quarter to $117B.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.